V008-1907 Screening compound: 2-[1,3-di-tert-butyl-4-(3-fluorophenyl)-7-oxo-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-[(pyridin-4-yl)methyl]acetamide

V008-1907 Screening compound: 2-[1,3-di-tert-butyl-4-(3-fluorophenyl)-7-oxo-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-[(pyridin-4-yl)methyl]acetamide
V008-1907 Screening compound: 2-[1,3-di-tert-butyl-4-(3-fluorophenyl)-7-oxo-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-[(pyridin-4-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V008-1907
2-[1,3-di-tert-butyl-4-(3-fluorophenyl)-7-oxo-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-[(pyridin-4-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V008-1907

Molecular Formula

C28H34FN5O2S (C28 H34 FN5 O2 S)

Compound Name

2-[1,3-di-tert-butyl-4-(3-fluorophenyl)-7-oxo-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-[(pyridin-4-yl)methyl]acetamide

IUPAC name

2-[13-di-tert-butyl-4-(3-fluorophenyl)-7-oxo-1H4H6H7H8H-pyrazolo[34-e][14]thiazepin-8-yl]-N-[(pyridin-4-yl)methyl]acetamide

SMILES

CC(C)(C)c1nn(C(C)(C)C)c(N2CC(NCc3ccncc3)=O)c1C(c1cc(F)ccc1)SCC2=O

InChI

InChI=1S/C28H34FN5O2S/c1-27(2,3)25-23-24(19-8-7-9-20(29)14-19)37-17-22(36)33(26(23)34(32-25)28(4,5)6)16-21(35)31-15-18-10-12-30-13-11-18/h7-14,24H,15-17H2,1-6H3,(H,31,35)/t24-/m1/s1

InChI Key

INVPSUPCDRYPSL-XMMPIXPASA-N

MDL Number (MFCD)

MFCD19799830

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

523.67

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.308

Distribution Coefficient, logD

4.305

Water Solubility, LogSw

-4.21

Polar Surface Area

65.163

Acid Dissociation Constant (pKa)

13.48

Base Dissociation Constant (pKb)

5.29

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.90

V008-1907 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V008-1907 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V008-1907?
Check Price and Availability of V008-1907, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V008-1907 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V008-1907
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V008-1907
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V008-1907 available by request